Study identifier:SD-039-0673
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Efficacy and safety of budesonide/formoterol (Symbicort) Turbuhaler as Single Therapy in patients with mild-moderate asthma. Comparison with Symbicort Turbuhaler and PulmicortTurbuhaler as maintenance therapy, both complemented with BricanylTurbuhaler (STAY).
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|